• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2200604 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-12-16 Guangdong Danxia Biology Pharmcy Co Ltd view
CYSB2101109 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-07-13 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2400098 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CYSB2200135 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-06-07 Shanghai RAAS Blood Products Co Ltd view
CYSB2400267 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-10-10 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CYSB2200070 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2022-03-10 Green Cross China Biological Products Co Ltd view
CYSB2101072 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-05-24 Hualan Biological Engineering Inc view
CYSB2400058 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-03-01 China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd view
CXSL2200012 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-01-12 Guangdong Danxia Biology Pharmcy Co Ltd view
CXSL2400412 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.2) New Drug Application 2024-06-26 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2200136 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-06-07 Shanghai RAAS Blood Products Co Ltd view
CXSL2200230 静注人免疫球蛋白 human immunoglobulin(PH4) Injection Biological Products(3.2) New Drug Application 2022-05-27 Shenzhen Weiguang Biological Products Co Ltd view
CXSL2400234 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2024-04-16 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2200065 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-03-01 Shenzhen Weiguang Biological Products Co Ltd view
CYSB2400260 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) Supplementary Application 2024-09-26 Shanxi Kangbao Biological Product Co Ltd view
CYSB2200109 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-04-29 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2101142 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-08-10 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2300149 静注人免疫球蛋白(10%) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2023-08-02 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CYSB2101073 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-05-24 Hualan Biological Engineering Inc view
CYSB2400114 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-05-15 Chengdu Rongsheng Pharmaceuticals Co Ltd view